PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 30, 2006 Subscribe to this News Feed    
 

Ultra Pure, Low-Cost Ryanodine Launched by Ascent Scientific - Helping Research into Heart Disease

Ascent Scientific (www.ascentscientific.com) announced the addition of ultra-pure Ryanodine to the Low-Cost Ligand™ range. Ryanodine is a standard tool, widely used by scientists for research into muscle physiology, signalling and heart disease.

Weston-s-Mare, UK (PRWeb) November 30, 2006 --Ascent Scientific have introduced Ryanodine at ultra high purity (>99%) and at prices around 50% less than many other suppliers. Ryanodine is the latest addition to the Low-Cost Ligand™ signalling range which also includes CGP 37157, ODQ and rolipram.

Iain Sandison Science Director commented, "We have received many requests from life scientists for a low-cost supply of Ryanodine. In response, we have introduced Ryanodine at a purity of greater than 99%, but around half the price of other suppliers. We are committed to progressing research by making high quality tools at affordable prices."

Contact: Steve Roome, Commercial Director +44 (0)1934 624 695

About Ascent Scientific
Ascent Scientific provides high quality receptor ligands, synthetic chemistry, research, consultancy and analytical services for life science, pharmaceutical and chemistry-related industries.

The Low-Cost Ligand™ range includes:
- Glutamate ligands (eg. Kainic acid, D-AP5, MPEP, CNQX)
- Ion Channel tools (eg. TTX)
- Opioids (eg. Naloxone, nor-BNI)
- Signalling tools (eg. Ryanodine, Rolipram, ODQ)
- And more…

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Steve Roome
Ascent Scientific
01934624695
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.